Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.
Loading...
Embargo End Date
Authors
Ruark, E
Seal, S
McDonald, H
Zhang, F
Elliot, A
Lau, K
Perdeaux, E
Rapley, E
Eeles, R
Peto, J
Kote-Jarai, Z
Muir, K
Nsengimana, J
Shipley, J
UK Testicular Cancer Collaboration (UKTCC),
Bishop, DT
Stratton, MR
Easton, DF
Huddart, RA
Rahman, N
Turnbull, C
Seal, S
McDonald, H
Zhang, F
Elliot, A
Lau, K
Perdeaux, E
Rapley, E
Eeles, R
Peto, J
Kote-Jarai, Z
Muir, K
Nsengimana, J
Shipley, J
UK Testicular Cancer Collaboration (UKTCC),
Bishop, DT
Stratton, MR
Easton, DF
Huddart, RA
Rahman, N
Turnbull, C
Document Type
Journal Article
Date
2013-06-01
Date Accepted
2013-04-10
Abstract
Testicular germ cell tumor (TGCT) is the most common cancer in young men and is notable for its high familial risks. So far, six loci associated with TGCT have been reported. From genome-wide association study (GWAS) analysis of 307,291 SNPs in 986 TGCT cases and 4,946 controls, we selected for follow-up 694 SNPs, which we genotyped in a further 1,064 TGCT cases and 10,082 controls from the UK. We identified SNPs at nine new loci (1q22, 1q24.1, 3p24.3, 4q24, 5q31.1, 8q13.3, 16q12.1, 17q22 and 21q22.3) showing association with TGCT (P < 5 × 10(-8)), which together account for an additional 4-6% of the familial risk of TGCT. The loci include genes plausibly related to TGCT development. PRDM14, at 8q13.3, is essential for early germ cell specification, and DAZL, at 3p24.3, is required for the regulation of germ cell development. Furthermore, PITX1, at 5q31.1, regulates TERT expression and is the third TGCT-associated locus implicated in telomerase regulation.
Citation
Nature genetics, 2013, 45 (6), pp. 686 - 689
DOI
Source Title
Publisher
NATURE PUBLISHING GROUP
ISSN
1061-4036
eISSN
1546-1718
Research Team
Predisposition & Translation Genetics
Genetic Susceptibility
Sarcoma Molecular Pathology
Clinical Academic Radiotherapy (Huddart)
Oncogenetics
Genetic Susceptibility
Sarcoma Molecular Pathology
Clinical Academic Radiotherapy (Huddart)
Oncogenetics
